RxDoctor Payments DataLook up a doctor →

Debbie Anderson

Family · Desloge, MONPI 1528417631

Payments from drug & device makers

$12,528in general payments, 2019–2025

Across 769 payments — averaging $16.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Lilly USA, LLC$755
  • Pfizer$692
  • Boehringer Ingelheim$523
  • Novo Nordisk$468
  • Amgen$463
  • plus $7K from 54 others

What the payments were for

  • Food & beverage$12,38099%
  • Education$1481%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie183$3,090
Lilly USA, LLC46$755
Pfizer58$692
Boehringer Ingelheim31$523
Novo Nordisk35$468
Amgen33$463
GSK34$448
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)26$429
Otsuka America Pharmaceutical, Inc.23$419
AstraZeneca24$419
Sumitomo Pharma America, Inc.20$334
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC21$308
Johnson & Johnson19$292
Astellas Pharma US Inc13$292
Axsome Therapeutics, Inc.8$287
Novartis13$249
Vanda Pharmaceuticals Inc.12$233
Lundbeck LLC13$230
Teva Pharmaceuticals USA, Inc.14$230
Merck13$210
Aimmune Therapeutics, Inc.10$179
Bayer9$155
E.r. Squibb & Sons, L.L.C.7$107
Mylan Specialty L.p.6$105
Ironwood Pharmaceuticals, Inc6$105
Amarin Pharma, Inc.6$102
Grifols USA, LLC5$90
Abbott5$86
Dexcom, Inc.4$79
Exact Sciences5$78
Nestle Healthcare Nutrition Inc.4$78
OPKO Pharmaceuticals, LLC4$73
Eisai Inc.5$66
Valinor Pharma, LLC4$65
Optinose US, Inc.4$59
Neurelis, Inc.4$57
Avanir Pharmaceuticals, Inc.3$52
Sunovion Pharmaceuticals Inc.4$51
Verona Pharma, Inc.3$48
Neurocrine Biosciences, Inc.2$42
Idorsia Pharmaceuticals US Inc2$40
Corium, LLC3$38
Viatris Specialty LLC2$36
Ardelyx, Inc.2$34
Antares Pharma, Inc.2$31
Sanofi-aventis U.S. LLC2$27
Collegium Pharmaceutical, Inc.2$27
Takeda Pharmaceuticals U.S.A., Inc.2$25
Biohaven Pharmaceuticals, Inc.1$24
Virtus Pharmaceuticals LLC2$24
Globus Medical1$22
Medtronic1$22
Avion Pharmaceuticals1$19
Phathom Pharmaceuticals, Inc.1$17
UCB, Inc.1$17
Protega Pharmaceutials Inc1$17
Jazz Pharmaceuticals Inc.1$16
Tactile Systems Technology Inc1$15
Gilead1$15
Organon1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,528 in reported general payments places this provider in the 95th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Medicare billing

Part B allowed, 2024
$48,325
Medicare patients
149
Services billed
829

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide133$145,937
OzempicSemaglutide120$139,738
FarxigaDapagliflozin Propanediol163$108,440
Trelegy ElliptaFluticasone/Umeclidin/Vilanter138$101,272
JardianceEmpagliflozin90$79,141
TrulicityDulaglutide54$72,976
RexultiBrexpiprazole38$57,551
LinzessLinaclotide74$42,875
MyrbetriqMirabegron67$41,872
Breztri AerosphereBudesonide/Glycopyr/Formoterol47$36,585
XareltoRivaroxaban41$28,443
EliquisApixaban34$28,114
Victoza 3-PakLiraglutide13$18,852
Spiriva HandihalerTiotropium Bromide19$16,052
VascepaIcosapent Ethyl40$15,997

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$755$218,913187 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort, Brilinta, Bevespi Aerosphere$419$170,748276 claims
Novo NordiskOzempic$468$139,738120 claims
GSKTrelegy Ellipta, Anoro Ellipta, Arexvy$448$115,219173 claims
Boehringer IngelheimJardiance$523$79,14190 claims
Otsuka America Pharmaceutical, Inc.Rexulti$419$57,55138 claims
AbbVieLinzess, Restasis$3,090$51,51089 claims
Astellas Pharma US IncMyrbetriq$292$41,87267 claims
Johnson & JohnsonXarelto$292$28,44341 claims
PfizerEliquis$692$28,11434 claims
BayerKerendia$155$14,33520 claims
MerckJanumet Xr$210$9,93414 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,812 family providers in Missouri.

Other family in Desloge

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →